Develop a coccidioides-specific antigen in patient serum or urine and develop an immunoassay for coccidioides galactomannan
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93020C00035
- Awardee
-
Dxdiscovery, Inc. UEI QLC3LDVHBSP8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,399
Award facts
- Opportunity
-
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (SBIR) contract proposals Solicitation · PHS20201 · Posted Jun 21, 2019
- Contract value 100% obligated
- $299,399.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 11 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Reno, NV 89557, USA
- Research
- STTR Phase I
- Legislative mandates
-
- Economy Act FAR subpart 17.5
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
Dxdiscovery Inc. was awarded a $299,399 firm fixed price Small Business Innovation Research Phase I contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for the development of a Coccidioides-specific antigen in patient serum or urine and an immunoassay for Coccidioides galactomannan. This award was made under a total small business set-aside solicitation seeking proposals to conduct research and development in support of NIH and CDC agency missions, including alternatives to cell culture materials and environmental health technologies. Dxdiscovery will perform the work in Reno, Nevada over a period of 14 months ending in October 2021.
Quick answers
Who was awarded contract 75N93020C00035?
75N93020C00035 was awarded to Dxdiscovery, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 14, 2020.
How much is contract 75N93020C00035 worth?
The government has obligated $299,399 on 75N93020C00035.
Was contract 75N93020C00035 competed?
The extent of competition for 75N93020C00035 was full and open competition after exclusion of sources. The government received 11 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award